D-0211-2026 Class II Ongoing
FDA drug recall D-0211-2026 was initiated by Blossom Pharmaceuticals on October 31, 2025 and is designated Class II. Reason for recall: cGMP deviations The recall status is ongoing. Affected quantity: 14700 bottles.
Recall Details
- Product Type
- Drugs
- Report Date
- December 10, 2025
- Initiation Date
- October 31, 2025
- Termination Date
- N/A
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 14700 bottles
Product Description
Globe Clotrimazole Cream USP, 1 % Antifungal Cream, Net Wt., 5 oz. (142 g, Distributed by: Trifecta Pharmaceuticals USA, 101 NE Third Avenue, Suite 1500, Ft. Lauderdale, FL 33301, USA, NDC 69396-087-55.
Reason for Recall
cGMP deviations
Distribution Pattern
USA Nationwide
Code Information
Lot #: A472418